In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Is A Universal Flu Vaccine Still A Lifetime Away?

Getting A Truly Universal Flu Vaccine To Market Will Be A Mammoth Task

Executive Summary

Influenza is a wily foe. It shows up each winter having taken a slightly different guise to outwit our existing immune defenses, but always keeps up its sleeve an ability to shapeshift to an entirely new form that could crash straight through them.

You may also be interested in...



BIO 2020 Notebook: Fauci On Price Controls; Biotech's Financing Advantage; Progress Towards Universal Flu Vaccine

News and views from day two of BIO Digital include Jim Greenwood on the prospects for drug development legislation.

BIO 2020 Notebook: Fauci On Price Controls; Biotech's Financing Advantage; Progress Towards Universal Flu Vaccine

News and views from day two of BIO Digital include Jim Greenwood on the prospects for drug development legislation.

Vaccine Development Challenges Include Extensive Quality Control, Sanofi's Loew Notes

Sanofi spends 70% of vaccine production on quality control, Sanofi Pasteur exec VP David Loew tells the Pink Sheet; company is working on next generation flu vaccines that may provide greater efficacy.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

IV124276

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel